Genetic modification in hematopoietic stem cells, using lentiviral vectors, to target protein expression in megakaryocyte and platelets
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frankfurt am Main, Johann Wolfgang Goethe-Universität, Dissertation, 2019
- Keyword
-
Blood platelets
Expression
Hematopoietic stem cells
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
- Contributor
-
Marschalek, Rolf
Modlich, Ute
- URN
-
urn:nbn:de:hebis:30:3-505149
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.02.2024, 1:28 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rey, Lisette Johana Latorre
- Marschalek, Rolf
- Modlich, Ute
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
Lentiviral vectors : with 8 tables
Targeted cell entry of lentiviral vectors
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Producing lentiviral vectors for ex vivo organ gene therapy
Downstream processing of lentiviral vectors with focus on steric exclusion chromatography
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Development of DC-specific lentiviral vectors: novel DC-targeting strategies for immunomodulation
Lentiviral vectors : with 8 tables
Targeted cell entry of lentiviral vectors
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Producing lentiviral vectors for ex vivo organ gene therapy
Downstream processing of lentiviral vectors with focus on steric exclusion chromatography
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Development of DC-specific lentiviral vectors: novel DC-targeting strategies for immunomodulation
Lentiviral vectors : with 8 tables
Targeted cell entry of lentiviral vectors
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Producing lentiviral vectors for ex vivo organ gene therapy
Downstream processing of lentiviral vectors with focus on steric exclusion chromatography
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression